Design and development of oral oil in water ramipril nanoemulsion formulation: In vitro and in vivo assessment

Journal of Biomedical Nanotechnology

Volumn 3, Issue 1, 2007, Pages 28-44

  Shafiq, Sheikh ^a   Shakeel, Faiyaz ^a   Talegaonkar, Sushma ^a   Ahmad, Farhan J ^a   Khar, Roop K ^a   Ali, Mushir ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Bioavailability; Nanoemulsion; Phase diagrams; Ramipril; Sefsol 218; SNEDDS; Solubility

Indexed keywords

CREMOPHOR; DIETHYLENE GLYCOL MONOETHYL ETHER; INTRALIPID; RAMIPRIL; RAMIPRILAT; SURFACTANT; WATER;

AREA UNDER THE CURVE; CONFERENCE PAPER; CONTROLLED STUDY; DILUTION; DISPERSION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; EMULSION; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PH; RAT; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; SUSPENSION; THERMODYNAMICS; VISCOSITY;

EID: 34548763353     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2007.008     Document Type: Conference Paper

References (37)

1. J. A. Bruce, Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. J. Pharm. Sci. 82, 979 (1993).
2. J. R. Robinson, Introduction: Semi-solid formulations for oral drug delivery. B. T. Gattefosse. 89, 11 (1996).
3. 10 Formulation development and bioavailability assessment. Int. J Pharm. 212, 233 (2001).
4. A. A. Date and V. B. Patravale, Current strategies for engineering drug nanoparticles. Curr. Opin. Colloid Interf. Sci. 9, 222 (2004).
5. K. Shinoda and H. Kunieda, Conditions to produce so-called microemulsions: Factors to increase the mutual solubility of oil and water by solubilizer. J. Colloid Interf. Sci. 42, 381 (1973).
6. V. H. Lee, Editorial: Nanotechnology: Challenging the limit of creativity in targeted drug delivery. Adv. Drug Deliv. Rev. 56, 1527 (2004).
7. K. Bouchemal, S, Briancon, E. Perrier, and H. Fessi, Nano-emulsion formulation using spontaneous emulsification: Solvent, oil, and surfactant optimization. Int. J. Pharm. 280, 241 (2004).
8. M. El-Aasser, C. D. Lack, J. W. Vanderhoff, and F. M. Fowkes, The mini-emulsion process - Different of spontaneous emulsification. Colloid. Surf. 29, 103 (1988).
9. M. J. Lawrence and G. D. Rees, Microemulsion-based media as novel drug delivery systems. Adv. Drug Deliv. Rev. 45, 89 (2000).
10. J. Eccleston, Microemulsions. Encyclopedia of Pharmaceutical Technology, edited by J. Swarbrick and J. C. Boylan. Marcel Dekker, NewYork (1994), Vol. 9, pp. 375-421.
11. P. P. Constantinides, Lipid microemulsions for improving drug dissolution and oral absorption and biopharmaceutical aspects. Pharm. Res. 12, 1561 (1995).
12. K. Kawakami, T. Yoshikawa, Y. Moroto, E. Kanaoka, K. Takahashi, Y. Nishihara, and K. Masuda, Microemulsion formulation for enhanced absorption of poorly soluble drugs I. Prescription design. J. Control. Rel. 81, 65 (2002).
13. K. Kawakami, T. Yoshikawa, Y. Moroto, E. Kanaoka, K. Takahashi, Y. Nishihara, and K. Masuda, Microemulsion formulation for enhanced absorption of poorly soluble drugs II. In vivo study. J. Control. Rel. 81, 75 (2002).
14. RxIist.com, the internet drug index. http://www.rxlist.coadcgi/generic/ ramipril_cp.htm
15. S. Yusuf, H. Gerstein, B. Hoogwerf, J. Pogue, J. Bosch, B. H. R. Wolffenbuttel, and B. Zinman, HOPE study investigators, ramipril and the development of diabetes. JAMA 286, 1882 (2001).
16. I. S. Malik, J. Bhatia, and J. S. Kooner, Is ramipril cost-effective as well as clinically useful in reducing cardiovascular risk. JACC, Abstracts-special topics (2001), p. 1247.
17. E. Wühl, O. Mehls, and F. Schaefer, Antihypenensive efficacy of ramipril in children with chronic renal failure. Am. J. Hyper. 16, 558 (2003).
18. Indian Pharmacopeia, Reagents and solutions, Appendix 13 (1996), pp. A144-A145.
19. C. W. Pouton, Formulation of self-emulsifying drug delivery systems. Adv. Drug Deliv. Rev. 25, 47 (1997).
20. S. M. Khoo, A. J. Humberstone, C. J. H. Potter, G. A. Edwards, and W. N. Charman, Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine. Int. J. Pharm. 167, 155 (1998).
21. D. Attwood, C. Mallon, G. Ktistis, and C. J. Taylor, A study on factors influencing the droplet size in nonionic oil-in-water microemulsions. Int. J. Pharm. 88, 417 (1992).
22. B. K. Kang, J. S. Lee, S. K. Chon, S. Y. Jeong, S. H. Yak, G. Khang, H. B. Lee, and S. H. Cho, Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int. J. Pharm. 274, 65 (2004).
23. F. Belal, I. A. AI-Zaagi, M. A. Gadkariem, and M. A. Abounassif, A stability-indicating LC method for the simultaneous determination of ramipril and hydrochloride in dosage forms. J. Pharm. Biomed. Anal. 24, 335 (2001).
24. M. N. Gosh, Fundamentals of Experimental Pharmacology, 3rd edn., Hilton and company, Kolkata, India (2005), p. 192.
25. J. Shaji and V. Joshi, Self-micro emulsifying drug delivery system (SMEDDS) for improving bioavailability of hydrophobic drugs and its potential to give sustain release dosage form. Indian J. Pharm. Educ. 39, 130 (2005).
26. L. Hanšgová, Václavková, J, Dohnal, and J. Klimeš, Stability of ramipril in the solvents of different pH. J. Pharm. Biomed. Anal. 24, 335 (2005).
27. B. L. Hogan, M. Williams, A. Idiculla, T. Veysoglu, and E. Parente, Development and validation of a liquid chromatographic method for the determination of the related substances of ramipril in Altace capsules. J. Pharm. Bionzed. Anal. 23, 637 (2000).
28. M. Grove, G. P. Pedersen, J. L. Nielsen, and A. Mullertz, Bioavailability of Seocalcitol I: Relating solubility in biorelevant media with oral bioavailability in rats - Effect of medium and long chain triglycerides. J. Pharm. Sci. 94, 1830 (2005).
29. W. Warisnoicharoen, A. B. Lansley, and M. J. Lawrence, Light scattering investigations on dilute non-ionic oil-in-water microemulsions. AAPS Pharm. Sci. 2, 429 (2000).
30. R. N. Gursoy and S. Benita. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed. Pharmacotherapy 58, 173 (2004).
31. D. Q. M. Craig, S. A. Barker, D. Banning, and S. W. Booth, An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy. Int. J. Pharm. 114, 103 (1995).
32. L. Ping, A. Ghosh, R. F. Wagner, S. Krill, Y. M. Joshi, and A. T. M. Serajuddin, Effect of combined use of nonionic surfactant on formation of oil-in-water microemulsions. Int. J. Pharm. 288, 27 (2005).
33. D. G. Levitt and R. C. Schoemaker, Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat. BMC Clin. Pharmacol. 6, 1 (2006).
34. J. M. V. Griensven, R. C. Schoemaker, A. F. Cohen, H. G. Luus, M. S. Grafe, and H. J. Rothig, Pharmacokinetics, pharmacodynamics, and bioavailability of the ACE inhibitor ramipril. Eur J. Clin. Pharmacol. 47, 513 (1995).
35. S. A. Charman, W. N. Charman, M. C. Rogge, T. D. Wilson, F. J. Dutko, and C. W. Pouton. Self-emulsifying drug delivery systems: Formulation and biopharmaceutic evaluation of an investigational lipophilic compound. Pharm. Res. 9, 87 (1992).
36. N. H. Shah, M. T. Carvajal, C. I. Patel, M. H. Infeld, and A. W. Malick, Selfemulsifying drug delivery systems (SEDDS) with polyglycolized glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int. J. Pharm. 106, 15 (1994).
37. C. K. Kim, Y. J. Cho, and Z. G. Gao, Preparation and evaluation of biphenyl dimethyl dicarboxylate microemulsions for oral delivery. J. Control. Rel. 70, 149 (2001).